Axa’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Axa’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-164,521	Closed	-$3.51M	–	1150
2024 Q1	$3.51M	Buy	+164,521	New	+$1.97M	0.01%	646

Axa's FUSN Position: Q2 2024 in Review

Axa sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 164,521 shares — an estimated $3.51M sold.

Axa first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $3.51M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Axa reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Axa sold 164,521 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $3.51M.
Axa first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Axa's Fusion Pharmaceuticals Inc. Common Shares position peaked at $3.51M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.